3 Stocks on Wait and Watch This Week
This week’s scans turned up very few clean setups worth featuring, a reflection of Nifty breaking below its key moving averages and the market entering a more cautious phase overall. Rather than force a longer list, this week’s watchlist is deliberately short: three stocks showing patterns still in development, none confirmed yet, all worth tracking rather than acting on.
AEGISLOG
ENERGY
AEGISLOG has been consolidating just below a resistance shelf after its earlier breakout run, forming a tightening pattern as it approaches its rising trendline. The one month move has cooled compared to its sharper earlier pace, but the three and six month trend remains firmly intact. This is a wait and watch name, worth tracking for whether it holds the rising trendline or breaks down through it.
BHEL
PSE
BHEL attempted a breakout above its recent resistance shelf before pulling back toward its rising trendline support. The three and six month trend remains strong, and this pullback looks more like a retest than a breakdown so far. Watch closely for whether it holds the trendline and attempts the breakout again, or slips further.
RADICO
FMCG
RADICO has been consolidating in a tight range just below its recent highs, neither breaking out nor giving back much ground. The three and six month trend remains solidly positive, but the one month pace has flattened, suggesting the stock needs a fresh catalyst to resolve this range. Worth watching which direction it breaks once it does.
Stocks featured in the Weekly Market Radar are selected for research and educational purposes only. They are not buy or sell recommendations.
Bottom line: All three names here are still developing rather than offering confirmed setups, which fits a week where Nifty itself has broken below its moving averages and very little else is showing clean momentum. AEGISLOG and BHEL are both testing rising trendline support after earlier strength, while RADICO is coiled in a tight range at its highs. With triple derivatives expiry, the Fed’s rate decision, and rising crude oil all landing this week, patience matters more than urgency. This is a starting point for your own research, not a signal to act on directly.